Entericolix

Clostridium perfringens tip C beta toxoid, E. coli, tulpina P4 (adezina F6), E. coli, tulpina P5 (adezina F18ab), E. coli, tulpina P6 (adezina F4ac), E. coli, tulpina P9 (adezina F18ac), E. coli, tulpina P10 (adezina F5 F41)

Product information

Trade name: Entericolix

Active substance: Clostridium perfringens tip C beta toxoid, E. coli, tulpina P4 (adezina F6), E. coli, tulpina P5 (adezina F18ab), E. coli, tulpina P6 (adezina F4ac), E. coli, tulpina P9 (adezina F18ac), E. coli, tulpina P10 (adezina F5 F41)

Therapeutic group: Organic products

Pharmaceutical form: emulsie injectabilă

Presentation: flacon x 50 ml (25 doze)

Target species: swine

Therapeutic action: Porcine (scroafe și scrofițe) Imunizarea pasivă a purceilor împotriva colibacilozei și enteritei necrotice cauzate de C. perfringens.

Waiting period: 0 zile.

Release mode: Cu prescripţie

Authorization data

Authorization number: 200180

Authorization status: Valida

Date of issue of the authorization: 11-11-2020

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: CZ VACCINES, S.A.U., Spania

Licensee: CZ VACCINES, S.A.U., Spania

Remarks: Autorizat prin DCP.